Study links childhood overweight to socioeconomic disadvantage

Last year’s lay­offs were just the start for Vir Biotech­nol­o­gy. The com­pa­ny is now shift­ing the di­rec­tion of its clin­i­cal and cor­po­rate op­er­a­tions by pri­or­i­tiz­ing

Im­mutep’s pro­tein-based can­cer treat­ment has suc­ceed­ed in a mid-stage study in pa­tients with head and neck squa­mous cell car­ci­no­ma, spurring dis­cus­sions with reg­u­la­tors on a